Risk of neuropsychiatric adverse events associated with varenicline treatment for smoking cessation among Dutch population: A sequence symmetry analysis

PURPOSE: Varenicline is an effective treatment for smoking cessation. While clinical trials did not confirm a causal role, case reports suggested a possible link of varenicline with neuropsychiatric adverse drug events (NPAEs). This study aims to investigate the risk of NPAEs associated with varenic...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuanyuan, van Boven, Job F. M., Bos, Jens H. J., Schuiling‐Veninga, Catharina C. M., Boezen, H. Marike, Wilffert, Bob, Hak, Eelko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292305/
https://www.ncbi.nlm.nih.gov/pubmed/34464494
http://dx.doi.org/10.1002/pds.5351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292305/
https://www.ncbi.nlm.nih.gov/pubmed/34464494
http://dx.doi.org/10.1002/pds.5351

Ejemplares similares